Form 4: Revolution Medicines Executive Sells Shares
Insider Transaction (Form 4)
Anthony Mancini, See Remarks of Revolution Medicines, Inc., sold 3,708 shares of common stock on September 24, 2026.
Summary
- Open-market sale: disposed of 587 Common Stock at $200.00 ($117,400) on September 24, 2026; holds 39,765 after (Direct).
- Option exercise/conversion: acquired 3,121 Common Stock at $33.62 ($104,928) on September 25, 2026; holds 42,886 after (Direct).
- Open-market sale: disposed of 3,121 Common Stock at $200.54 ($625,885) on September 25, 2026; holds 39,765 after (Direct).
- Option exercise/conversion: disposed of 3,121 Stock Option (Right to Buy) on September 25, 2026; holds 93,625 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $743,285 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Anthony Mancini — Officer (See Remarks)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-24 | Open-market sale | Common Stock | 587 | $200 | $117.4K | 39,765 |
| 2026-09-25 | Option exercise/conversion | Common Stock | 3,121 | $34 | $104.9K | 42,886 |
| 2026-09-25 | Open-market sale | Common Stock | 3,121 | $201 | $625.9K | 39,765 |
| 2026-09-25 | Option exercise/conversion | Stock Option (Right to Buy) | 3,121 | — | — | 93,625 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-24 | Open-market sale (587 shares) |
| 2026-09-25 | Option exercise/conversion (3,121 shares) |
| 2026-09-25 | Open-market sale (3,121 shares) |
| 2026-09-25 | Option exercise/conversion (3,121 shares) |
Keywords
insider transaction, Form 4, RVMD, Revolution Medicines, Inc., bearish, Anthony Mancini
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.